General Information
Revision date
2021-08-12
Product name
LAMIVUDINE 100MG TABLETS
Product Synonyms
3TC * 3TC TABLETS * 3TC-HBV * HEPTOVIR * ZEFFIX * ZEFFIX 100 MG FILM-COATED
CAS No.
134678-17-4
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
ViiV Healthcare Limited
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361, H373
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Reproductive toxicity Category 2 H361 - Suspected of damaging fertility or the unborn child. Specific target organ toxicity - repeated Category 2 H373 - May cause damage to exposure organs through prolonged or repeated exposure. Hazard summary Caution - Pharmaceutical agent. May cause damage to organs through prolonged or repeated exposure. Possible reproductive hazard. Occupational exposure to the substance or mixture may cause adverse health effects. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
LAMIVUDINE
Signal word
Warning
Hazard statements
H361 Suspected of damaging fertility or the unborn child. H373 May cause damage to organs through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
45,6 % of the mixture consists of component(s) of unknown acute oral toxicity. 87,34 % of the mixture consists of component(s) of unknown acute dermal toxicity. 48,24 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 48,24 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Assume that this material is capable of sustaining combustion. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
